Nautilus Biotechnology Inc
NASDAQ:NAUT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nautilus Biotechnology Inc
NASDAQ:NAUT
|
US |
|
PG Electroplast Ltd
NSE:PGEL
|
IN |
|
L
|
LPKF Laser & Electronics AG
OTC:LPKFF
|
DE |
|
Entravision Communications Corp
NYSE:EVC
|
US |
|
Smc Entertainment Inc
OTC:SMCE
|
US |
|
I
|
Irish Residential Properties REIT PLC
ISEQ:IRES
|
IE |
|
Also Holding AG
SIX:ALSN
|
CH |
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
N
|
Northern Trust Corp
XBER:NT4
|
US |
|
C
|
Cloudflare Inc
XMUN:8CF
|
US |
|
P
|
Pfizer Inc
BMV:PFE
|
US |
Wall St Price Targets
NAUT Price Targets Summary
Nautilus Biotechnology Inc
According to Wall Street analysts, the average 1-year price target for
NAUT is 4.08 USD with a low forecast of 4.04 USD and a high forecast of 4.2 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NAUT's stock price target?
Price Target
4.08
USD
According to Wall Street analysts, the average 1-year price target for
NAUT is 4.08 USD with a low forecast of 4.04 USD and a high forecast of 4.2 USD.